Abstract

BackgroundParkinson’s disease patients are at an elevated risk of developing cognitive impairment. Although cognitive impairment is one of the strongest predictors of quality of life, dopaminergic anti-parkinsonian medications are designed to target motor symptoms. However, there is substantial evidence that dopamine also impacts cognition, in particular working memory. It is therefore critical for movement disorders physicians to understand the potential dopaminergic effects on working memory when prescribing these medications.Verbal digit span tasks offer a potentially straightforward and quick assessment of baseline working memory. Moreover, Digit Span Backward was recently validated as a screening tool for mild cognitive impairment in Parkinson’s disease when participants were medicated. Research indicates that the interaction between dopamine and working memory follows an Inverted-U shaped curve, but the effect of dopamine on Digit Span has not been well studied.Our study seeks to: (1) determine the validity of verbal Digit Spans for detecting cognitive impairment in Parkinson’s disease patients both ON and OFF medications; and (2) ascertain the effects of dopaminergic medications on verbal Digit Span.MethodsWe recruited 64 Parkinson’s disease patients and 22 age-and education-matched controls. Parkinson’s patients completed Digit Span Backward and Digit Span Forward ON and OFF medications, while healthy controls completed them once. All participants were categorized by cognitive diagnosis using level-II consensus criteria.ResultsDigit Span Backward successfully identified mild cognitive impairment in Parkinson’s disease, both ON and OFF medications. Combining patients with and without cognitive impairment, we found that dopamine significantly improved performance on Digit Span Backward, but not Forward. In a secondary analysis, we found this dopaminergic improvement was restricted to the Low baseline working memory group; the High baseline working memory group was unaffected.ConclusionsThis study provides evidence for Digit Span Backward as a screening tool for working memory impairment in Parkinson’s disease and for its utility in measuring baseline working memory. Moreover, it reveals a partial beneficial effect of dopamine on Digit Span in Parkinson’s disease patients.

Highlights

  • Parkinson’s disease patients are at an elevated risk of developing cognitive impairment

  • Demographics healthy controls (HC) participants were age-matched with the overall Parkinson’s disease (PD) group and with the PD Parkinson’s disease without cognitive impairment (no-MCI) and PD with mild cognitive impairment (PD-MCI) groups.) HC and PD no-MCI groups were significantly younger than the PD with dementia (PDD) group

  • There were no significant differences between the HC and PD no-MCI groups on any of the neuropsychological tests administered (Table 2). 59 participants completed the digit span ON and OFF dopaminergic medications, 1 completed it only OFF medications, and 4 completed it only ON medications

Read more

Summary

Introduction

Parkinson’s disease patients are at an elevated risk of developing cognitive impairment. The model holds strong implications for the effects of dopaminergic medications on cognition in PD patients in particular; individuals with intrinsic deficits might benefit from dopamine replacement while those with more superior baseline WM capabilities might suffer. For this reason, it is crucial for clinicians to be able to accurately determine baseline levels of WM in PD patients and predict the effects of dopaminergic medications on WM

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call